Financial

Study published in the New England Journal of Medicine AI Concludes that the Sepsis ImmunoScore™, the First FDA-Authorized AI Tool for Sepsis, has both significant Diagnostic and Predictive Power

Groundbreaking NEJM AI Study Highlights the Ability of Prenosis' Sepsis ImmunoScore™ to Holistically Predict Adverse Outcomes, Ushering in a New...

FDA Authorizes Beacon’s Dreem 3S as First Sleep Wearable with Predetermined Change Control Plan, Paving the Way for Continuous Algorithm Enhancements in Sleep Monitoring

BOSTON, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Beacon Biosignals is proud to announce FDA authorization of the Predetermined Change Control Plan...

Segmed’s real-world imaging data solution to be integrated into Bayer platform to accelerate the development of AI-powered healthcare solutions

Segmed's 100 million imaging studies will help power the new AI innovation platform from Bayer in Radiology, enabling organizations to build AI-powered...

error: Content is protected !!